Prof Luigi Gennari, MD, PhD
Internal medicine — University of Siena, Italy
Luigi Gennari
LeadR Profile
Internal medicine
Subspecialties: Endocrinology - Nutrition - Rheumatology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1988 - 2026
Number : 357
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Development and Internal Validation of a Clinical Risk Score for Hypovitaminosis D in Italian Adults Aged ≥50 Years Attending Osteoporosis and Metabolic Bone Disease Centers. research design, chronic disease, absenteeism, bone diseases, metabolic, vitamins, bone diseases, food, aged, osteoporosis, cholecalciferol | Nutrients | 2026 | 0 |
| Bone Marrow Edema Syndrome as an Emerging Clinical Condition: Investigating the Link with Bone Status-A Single-Center Study. bone marrow, bone remodeling, vitamins, osteoporosis, prevalence, edema | J Clin Med | 2026 | 0 |
| Editorial: Emerging therapies for metabolic bone diseases. bone diseases, metabolic, bone diseases, therapeutics | Front Endocrinol (Lausanne) | 2026 | 0 |
| Osteoporosis associated with pregnancy and lactation (PLO): can REMS have a role in prevention and follow-up? pregnancy, lactation, multiple chronic conditions, osteoporosis, diagnosis | Endocrinol Diabetes Metab Case Rep | 2026 | 0 |
| Across Clinical Profiles of Cardiorenal-Metabolic (CKM) Syndrome: A Phenotype-Driven Therapeutic Approach. heart failure, diabetic nephropathies, cardiovascular diseases, phenotype, kidney, obesity, therapeutics, diabetes mellitus, type 2 | Biomedicines | 2026 | 1 |
Clinical Studies 5
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Institution of an Italian Multicenter Database of Patients with Parathyroid Carcinoma or Atypical Parathyroid Adenoma NCT06645951 — pharmaceutical preparations, data collection, neoplasms, parathyroid neoplasms, pathology, adenoma, therapeutics, genetic diseases, inborn, parathyroid glands, carcinoma, male | N/A | Recruiting | 2024 |
| Institution of an Italian Multicenter Database of Patients Affected by Hypoparathyroidism or Pseudohypoparathyroidism NCT06645899 — endocrinology, hypoparathyroidism, incidence, data collection, pathology, pseudohypoparathyroidism, prevalence, pseudopseudohypoparathyroidism, therapeutics, male, bone and bones | N/A | Recruiting | 2024 |
| Sequential Therapies After Osteoanabolic Treatment NCT06164795 — injections, zoledronic acid, teriparatide, denosumab, osteoporosis, osteoporosis, postmenopausal, therapeutics, infusions, intravenous, injections, subcutaneous, women | N/A | Recruiting | 2023 |
| Type 2 Diabetes Obesity and Cortisol Excess NCT05759637 — diabetes mellitus, research design, dexamethasone, prevalence, obesity, hydrocortisone, cushing syndrome, diabetes mellitus, type 2 | N/A | Recruiting | 2022 |
| Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study) NCT05575167 — vitamin d, zoledronic acid, vitamins, alendronate, digestion, denosumab, osteoporosis, calcium, osteoporosis, postmenopausal, tissues, bone and bones | N/A | Active not recruiting | 2023 |
LeadR Networks
Main global connection map